Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- NKF 2025 Survey: Patients Want More Home Dialysis Options Posted 01-13-2025
- Annual PD Machine Operating Cost is $24/mo or Less Posted 01-13-2025
- Premier Dialysis Videos: How to Read and Use PD Bags From Other Countries Posted 01-13-2025
- Medicare’s 2025 Physician Fee Schedule Posted 01-13-2025